| cholesterol metabolic process | GO:0008203 | 56 | 1.000 | |
| sterol metabolic process | GO:0016125 | 58 | 1.000 | |
| cholesterol homeostasis | GO:0042632 | 44 | 1.000 | |
| protein lipid complex subunit organization | GO:0071825 | 12 | 1.000 | |
| sterol transport | GO:0015918 | 38 | 1.000 | |
| neutral lipid metabolic process | GO:0006638 | 57 | 1.000 | Human Mouse |
| positive regulation of sterol transport | GO:0032373 | 9 | 1.000 | Human |
| lipid homeostasis | GO:0055088 | 63 | 1.000 | |
| regulation of plasma lipoprotein particle levels | GO:0097006 | 23 | 1.000 | |
| regulation of phosphatidylcholine catabolic process | GO:0010899 | 2 | 1.000 | |
| triglyceride metabolic process | GO:0006641 | 51 | 1.000 | Human Mouse |
| sterol homeostasis | GO:0055092 | 45 | 1.000 | |
| sterol transmembrane transport | GO:0035382 | 2 | 1.000 | |
| cholesterol transport | GO:0030301 | 38 | 1.000 | |
| reverse cholesterol transport | GO:0043691 | 6 | 1.000 | Human |
| acylglycerol homeostasis | GO:0055090 | 16 | 0.999 | Mouse |
| response to low density lipoprotein particle | GO:0055098 | 2 | 0.999 | |
| cholesterol esterification | GO:0034435 | 3 | 0.999 | |
| positive regulation of lipid metabolic process | GO:0045834 | 40 | 0.999 | |
| acylglycerol metabolic process | GO:0006639 | 55 | 0.999 | Human Mouse |
| positive regulation of lipid transport | GO:0032370 | 22 | 0.999 | Human |
| positive regulation of triglyceride metabolic process | GO:0090208 | 9 | 0.999 | |
| sterol esterification | GO:0034434 | 3 | 0.999 | |
| lipid catabolic process | GO:0016042 | 69 | 0.999 | |
| positive regulation of cholesterol transport | GO:0032376 | 9 | 0.999 | Human |
| triglyceride homeostasis | GO:0070328 | 15 | 0.999 | |
| regulation of beta amyloid clearance | GO:1900221 | 1 | 0.999 | Human |
| plasma lipoprotein particle organization | GO:0071827 | 11 | 0.998 | |
| acylglycerol biosynthetic process | GO:0046463 | 18 | 0.998 | |
| regulation of triglyceride metabolic process | GO:0090207 | 17 | 0.998 | |
| glycerolipid metabolic process | GO:0046486 | 122 | 0.998 | Human Mouse |
| regulation of cholesterol metabolic process | GO:0090181 | 14 | 0.998 | Human |
| cellular ketone metabolic process | GO:0042180 | 84 | 0.997 | |
| intracellular cholesterol transport | GO:0032367 | 3 | 0.997 | |
| cholesterol storage | GO:0010878 | 4 | 0.997 | |
| cholesterol efflux | GO:0033344 | 24 | 0.997 | |
| cholesterol import | GO:0070508 | 2 | 0.996 | |
| organic hydroxy compound transport | GO:0015850 | 93 | 0.996 | |
| macromolecular complex remodeling | GO:0034367 | 6 | 0.996 | |
| small molecule catabolic process | GO:0044282 | 71 | 0.996 | |
| high density lipoprotein particle assembly | GO:0034380 | 3 | 0.995 | Human |
| intestinal absorption | GO:0050892 | 13 | 0.995 | Mouse |
| regulation of cellular ketone metabolic process | GO:0010565 | 66 | 0.995 | |
| peptidyl tyrosine modification | GO:0018212 | 145 | 0.995 | |
| organic anion transport | GO:0015711 | 137 | 0.995 | Human |
| phospholipid transfer to membrane | GO:0006649 | 2 | 0.995 | |
| regulation of removal of superoxide radicals | GO:2000121 | 4 | 0.994 | |
| amine metabolic process | GO:0009308 | 45 | 0.994 | |
| glycerolipid catabolic process | GO:0046503 | 16 | 0.994 | |
| steroid metabolic process | GO:0008202 | 119 | 0.994 | |
| positive regulation of cholesterol efflux | GO:0010875 | 9 | 0.994 | Human |
| phospholipid transport | GO:0015914 | 21 | 0.994 | Human |
| regulation of defense response | GO:0031347 | 233 | 0.994 | |
| regulation of fatty acid metabolic process | GO:0019217 | 28 | 0.994 | |
| regulation of cellular amino acid metabolic process | GO:0006521 | 5 | 0.994 | |
| cellular amide metabolic process | GO:0043603 | 58 | 0.993 | Human |
| positive regulation of phagocytosis | GO:0050766 | 26 | 0.991 | |
| formation of radial glial scaffolds | GO:0021943 | 4 | 0.991 | |
| alcohol metabolic process | GO:0006066 | 116 | 0.990 | |
| steroid esterification | GO:0034433 | 3 | 0.990 | |
| phospholipid catabolic process | GO:0009395 | 5 | 0.990 | |
| positive regulation of cellular amine metabolic process | GO:0033240 | 5 | 0.989 | |
| activation of membrane attack complex | GO:0001905 | 4 | 0.988 | |
| regulation of cellular amine metabolic process | GO:0033238 | 20 | 0.988 | |
| immune response activating signal transduction | GO:0002757 | 116 | 0.987 | |
| phospholipid efflux | GO:0033700 | 3 | 0.987 | Human |
| plasma lipoprotein particle remodeling | GO:0034369 | 6 | 0.985 | |
| regulation of kinase activity | GO:0043549 | 249 | 0.985 | Human |
| regulation of cytokine production | GO:0001817 | 266 | 0.984 | |
| glycerolipid biosynthetic process | GO:0045017 | 50 | 0.984 | |
| plasma lipoprotein particle clearance | GO:0034381 | 13 | 0.984 | Human |
| regulation of triglyceride biosynthetic process | GO:0010866 | 10 | 0.984 | |
| regulation of lipoprotein lipase activity | GO:0051004 | 4 | 0.983 | |
| regulation of transferase activity | GO:0051338 | 263 | 0.982 | Human Mouse |
| lipid storage | GO:0019915 | 36 | 0.982 | Mouse |
| positive regulation of lipid storage | GO:0010884 | 10 | 0.981 | |
| coagulation | GO:0050817 | 78 | 0.981 | Human |
| organophosphate ester transport | GO:0015748 | 28 | 0.980 | Human |
| positive regulation of defense response | GO:0031349 | 124 | 0.979 | |
| lipid transport | GO:0006869 | 98 | 0.979 | |
| regulation of phagocytosis engulfment | GO:0060099 | 5 | 0.975 | |
| phospholipid metabolic process | GO:0006644 | 87 | 0.975 | Mouse |
| positive regulation of reactive oxygen species metabolic process | GO:2000379 | 11 | 0.971 | |
| cellular response to cytokine stimulus | GO:0071345 | 189 | 0.971 | |
| cytokine production | GO:0001816 | 319 | 0.969 | |
| peptidyl amino acid modification | GO:0018193 | 336 | 0.969 | |
| organic hydroxy compound catabolic process | GO:1901616 | 25 | 0.969 | |
| response to lipoprotein particle | GO:0055094 | 5 | 0.967 | |
| superoxide metabolic process | GO:0006801 | 27 | 0.965 | |
| regulation of response to wounding | GO:1903034 | 189 | 0.963 | |
| cellular amine metabolic process | GO:0044106 | 44 | 0.962 | |
| organic hydroxy compound metabolic process | GO:1901615 | 203 | 0.958 | |
| positive regulation of kinase activity | GO:0033674 | 155 | 0.956 | |
| positive regulation of phagocytosis engulfment | GO:0060100 | 3 | 0.955 | |
| neutral lipid biosynthetic process | GO:0046460 | 18 | 0.955 | |
| regulation of phospholipid catabolic process | GO:0060696 | 2 | 0.954 | |
| defense response to gram positive bacterium | GO:0050830 | 50 | 0.953 | |
| triglyceride biosynthetic process | GO:0019432 | 17 | 0.951 | |
| maintenance of location | GO:0051235 | 89 | 0.949 | |
| lipid localization | GO:0010876 | 126 | 0.948 | |
| reactive oxygen species metabolic process | GO:0072593 | 84 | 0.947 | |
| positive regulation of mapk cascade | GO:0043410 | 170 | 0.946 | |
| stress response to metal ion | GO:0097501 | 3 | 0.945 | |
| phospholipid homeostasis | GO:0055091 | 6 | 0.945 | |
| positive regulation of reverse cholesterol transport | GO:1903064 | 1 | 0.945 | |
| intracellular lipid transport | GO:0032365 | 3 | 0.943 | |
| neuron apoptotic process | GO:0051402 | 142 | 0.942 | |
| sterol import | GO:0035376 | 2 | 0.937 | |
| cellular lipid catabolic process | GO:0044242 | 52 | 0.937 | |
| positive regulation of glial cell proliferation | GO:0060252 | 4 | 0.935 | |
| negative regulation of inflammatory response | GO:0050728 | 61 | 0.935 | |
| response to organic cyclic compound | GO:0014070 | 198 | 0.932 | Mouse |
| regulation of lipid biosynthetic process | GO:0046890 | 54 | 0.932 | Human |
| negative regulation of fat cell differentiation | GO:0045599 | 36 | 0.928 | |
| regulation of inflammatory response | GO:0050727 | 147 | 0.927 | |
| cellular response to oxygen radical | GO:0071450 | 14 | 0.923 | |
| carbohydrate metabolic process | GO:0005975 | 230 | 0.922 | |
| response to hyperoxia | GO:0055093 | 2 | 0.920 | |
| response to oxygen levels | GO:0070482 | 62 | 0.919 | |
| cellular amino acid metabolic process | GO:0006520 | 103 | 0.916 | |
| intestinal cholesterol absorption | GO:0030299 | 5 | 0.914 | Mouse |
| positive regulation of protein modification process | GO:0031401 | 299 | 0.912 | |
| liver development | GO:0001889 | 66 | 0.911 | |
| positive regulation of cytokine production | GO:0001819 | 174 | 0.911 | |
| low density lipoprotein particle clearance | GO:0034383 | 8 | 0.908 | |
| regulation of growth of symbiont in host | GO:0044126 | 19 | 0.906 | |
| metanephric glomerular mesangium development | GO:0072223 | 3 | 0.905 | |
| defense response to bacterium | GO:0042742 | 119 | 0.904 | |
| positive regulation of apoptotic process involved in mammary gland involution | GO:0060058 | 4 | 0.903 | |
| acute inflammatory response | GO:0002526 | 41 | 0.897 | |
| activation of immune response | GO:0002253 | 138 | 0.896 | |
| cdc42 protein signal transduction | GO:0032488 | 0 | 0.895 | Human |
| defense response to other organism | GO:0098542 | 197 | 0.894 | |
| regulation of protein processing | GO:0070613 | 96 | 0.893 | |
| mapk cascade | GO:0000165 | 281 | 0.890 | Human |
| drug catabolic process | GO:0042737 | 2 | 0.890 | |
| vitamin metabolic process | GO:0006766 | 23 | 0.890 | |
| regulation of cell migration | GO:0030334 | 219 | 0.890 | Human |
| blood vessel morphogenesis | GO:0048514 | 285 | 0.887 | |
| transmission of nerve impulse | GO:0019226 | 76 | 0.886 | |
| beta amyloid clearance | GO:0097242 | 2 | 0.885 | Human |
| positive regulation of lipid biosynthetic process | GO:0046889 | 18 | 0.883 | Human |
| respiratory system development | GO:0060541 | 190 | 0.883 | |
| regulation of planar cell polarity pathway involved in outflow tract morphogenesis | GO:2000163 | 1 | 0.882 | |
| regulation of acute inflammatory response | GO:0002673 | 27 | 0.881 | |
| regulation of lipase activity | GO:0060191 | 15 | 0.879 | |
| humoral immune response | GO:0006959 | 57 | 0.877 | |
| regulation of reactive oxygen species metabolic process | GO:2000377 | 40 | 0.876 | |
| negative regulation of planar cell polarity pathway involved in pericardium morphogenesis | GO:2000166 | 1 | 0.876 | |
| response to inorganic substance | GO:0010035 | 96 | 0.876 | |
| cellular response to peptide | GO:1901653 | 92 | 0.874 | |
| regulation of cholesterol esterification | GO:0010872 | 2 | 0.873 | |
| cellular response to tumor necrosis factor | GO:0071356 | 21 | 0.872 | |
| cellular response to amino acid stimulus | GO:0071230 | 29 | 0.871 | |
| cytokine mediated signaling pathway | GO:0019221 | 115 | 0.870 | |
| peptidyl tyrosine phosphorylation | GO:0018108 | 143 | 0.868 | |
| negative regulation of planar cell polarity pathway involved in cardiac right atrium morphogenesis | GO:2000162 | 1 | 0.868 | |
| cation homeostasis | GO:0055080 | 212 | 0.863 | |
| positive regulation of endocytosis | GO:0045807 | 42 | 0.860 | |
| adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002460 | 145 | 0.859 | |
| regulation of phospholipase a2 activity | GO:0032429 | 3 | 0.856 | |
| positive regulation of apoptotic cell clearance | GO:2000427 | 3 | 0.856 | |
| response to metal ion | GO:0010038 | 47 | 0.855 | |
| negative regulation of growth of symbiont in host | GO:0044130 | 19 | 0.855 | |
| cellular response to molecule of bacterial origin | GO:0071219 | 83 | 0.853 | |
| regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | GO:2000148 | 1 | 0.852 | |
| positive regulation of beta amyloid clearance | GO:1900223 | 1 | 0.846 | |
| response to lipopolysaccharide | GO:0032496 | 128 | 0.843 | |
| glycerophospholipid metabolic process | GO:0006650 | 71 | 0.839 | |
| respiratory tube development | GO:0030323 | 167 | 0.838 | |
| response to oxygen radical | GO:0000305 | 16 | 0.838 | |
| response to insulin | GO:0032868 | 100 | 0.837 | |
| positive regulation of protein phosphorylation | GO:0001934 | 242 | 0.836 | |
| intracellular sterol transport | GO:0032366 | 3 | 0.834 | |
| regulation of sterol transport | GO:0032371 | 17 | 0.827 | Human Mouse |
| response to lithium ion | GO:0010226 | 10 | 0.826 | |
| chemotaxis | GO:0006935 | 247 | 0.822 | |
| positive regulation of peptidyl tyrosine phosphorylation | GO:0050731 | 61 | 0.821 | |
| striated muscle tissue development | GO:0014706 | 293 | 0.818 | |
| response to corticosterone | GO:0051412 | 1 | 0.816 | |
| negative regulation of interferon gamma mediated signaling pathway | GO:0060336 | 1 | 0.813 | |
| positive regulation of lipoprotein lipase activity | GO:0051006 | 3 | 0.811 | |
| protein kinase b signaling | GO:0043491 | 74 | 0.807 | |
| positive regulation of transferase activity | GO:0051347 | 167 | 0.802 | Mouse |
| cellular lipid metabolic process | GO:0044255 | 323 | 0.801 | |
| regulation of mapk cascade | GO:0043408 | 248 | 0.801 | Human |
| regulation of glutamine family amino acid metabolic process | GO:0000820 | 1 | 0.798 | |
| anion homeostasis | GO:0055081 | 16 | 0.796 | Human |
| complement activation | GO:0006956 | 16 | 0.794 | |
| positive regulation of insulin receptor signaling pathway | GO:0046628 | 4 | 0.791 | |
| positive regulation of protein serine threonine kinase activity | GO:0071902 | 106 | 0.790 | |
| fatty acid biosynthetic process | GO:0006633 | 41 | 0.788 | |
| positive regulation of cellular amino acid metabolic process | GO:0045764 | 3 | 0.784 | |
| cellular biogenic amine metabolic process | GO:0006576 | 28 | 0.784 | |
| myeloid leukocyte activation | GO:0002274 | 83 | 0.783 | |
| regulation of nitrogen cycle metabolic process | GO:1903314 | 1 | 0.783 | |
| reactive nitrogen species metabolic process | GO:2001057 | 0 | 0.783 | |
| regulation of cell projection organization | GO:0031344 | 206 | 0.781 | Human |
| negative regulation of protein processing | GO:0010955 | 79 | 0.778 | |
| regulation of response to oxidative stress | GO:1902882 | 19 | 0.776 | |
| removal of superoxide radicals | GO:0019430 | 12 | 0.776 | |
| response to steroid hormone | GO:0048545 | 56 | 0.776 | |
| neuron death | GO:0070997 | 154 | 0.764 | Human |
| lipoprotein metabolic process | GO:0042157 | 43 | 0.759 | |
| regulation of protein maturation | GO:1903317 | 96 | 0.759 | |
| divalent inorganic cation homeostasis | GO:0072507 | 138 | 0.758 | |
| lipid modification | GO:0030258 | 65 | 0.757 | |
| regulation of cytokine production involved in immune response | GO:0002718 | 26 | 0.752 | |
| plasma lipoprotein particle assembly | GO:0034377 | 6 | 0.751 | Human |
| dna metabolic process | GO:0006259 | 303 | 0.749 | |
| epithelial cell migration | GO:0010631 | 63 | 0.747 | Human Mouse |
| regulation of neuron death | GO:1901214 | 134 | 0.745 | Human |
| leukocyte mediated immunity | GO:0002443 | 174 | 0.744 | |
| regulation of peptidyl tyrosine phosphorylation | GO:0050730 | 93 | 0.743 | |
| blood vessel endothelial cell migration | GO:0043534 | 23 | 0.741 | Human Mouse |
| cell chemotaxis | GO:0060326 | 81 | 0.739 | |
| negative regulation of response to wounding | GO:1903035 | 77 | 0.738 | |
| negative regulation of protein metabolic process | GO:0051248 | 282 | 0.736 | Human |
| response to extracellular stimulus | GO:0009991 | 127 | 0.736 | |
| positive regulation of secretion by cell | GO:1903532 | 114 | 0.735 | |
| response to amino acid | GO:0043200 | 37 | 0.727 | |
| protein activation cascade | GO:0072376 | 19 | 0.727 | |
| regulation of protein serine threonine kinase activity | GO:0071900 | 157 | 0.726 | Human |
| glycerophospholipid catabolic process | GO:0046475 | 5 | 0.725 | |
| regulation of angiogenesis | GO:0045765 | 81 | 0.724 | |
| positive regulation of protein kinase activity | GO:0045860 | 144 | 0.723 | |
| response to increased oxygen levels | GO:0036296 | 2 | 0.722 | |
| negative regulation of cytokine production | GO:0001818 | 84 | 0.722 | |
| cellular response to growth factor stimulus | GO:0071363 | 197 | 0.719 | |
| receptor biosynthetic process | GO:0032800 | 3 | 0.719 | |
| modulation of growth of symbiont involved in interaction with host | GO:0044144 | 19 | 0.718 | |
| positive regulation of inflammatory response | GO:0050729 | 47 | 0.716 | |
| positive regulation of cell migration | GO:0030335 | 109 | 0.713 | |
| regulation of cholesterol transport | GO:0032374 | 17 | 0.712 | Human Mouse |
| regulation of membrane potential | GO:0042391 | 192 | 0.711 | |
| response to molecule of bacterial origin | GO:0002237 | 143 | 0.711 | |
| positive regulation of innate immune response | GO:0045089 | 80 | 0.710 | |
| negative regulation of inflammatory response to antigenic stimulus | GO:0002862 | 10 | 0.710 | |
| regulation of endocytosis | GO:0030100 | 69 | 0.706 | |
| response to superoxide | GO:0000303 | 16 | 0.705 | |
| regulation of reactive oxygen species biosynthetic process | GO:1903426 | 2 | 0.703 | |
| membrane invagination | GO:0010324 | 17 | 0.702 | |
| positive regulation of response to wounding | GO:1903036 | 66 | 0.694 | |
| cell adhesion | GO:0007155 | 329 | 0.689 | |
| response to reactive oxygen species | GO:0000302 | 56 | 0.688 | |
| regulation of lipid catabolic process | GO:0050994 | 15 | 0.688 | |
| ethanolamine containing compound metabolic process | GO:0042439 | 18 | 0.687 | |
| regulation of fat cell differentiation | GO:0045598 | 81 | 0.686 | |
| protein lipid complex remodeling | GO:0034368 | 6 | 0.684 | |
| negative regulation of apoptotic signaling pathway | GO:2001234 | 104 | 0.683 | |
| multicellular organismal signaling | GO:0035637 | 91 | 0.681 | |
| fatty acid metabolic process | GO:0006631 | 121 | 0.680 | |
| endothelial cell migration | GO:0043542 | 44 | 0.679 | Human Mouse |
| positive regulation of programmed cell death | GO:0043068 | 218 | 0.676 | |
| regulation of presynaptic membrane organization | GO:1901629 | 3 | 0.674 | Human |
| leukocyte chemotaxis | GO:0030595 | 69 | 0.666 | |
| protein localization to nucleus | GO:0034504 | 121 | 0.663 | |
| regulation of phospholipid efflux | GO:1902994 | 2 | 0.663 | Human |
| regulation of innate immune response | GO:0045088 | 91 | 0.659 | |
| negative regulation of growth of symbiont involved in interaction with host | GO:0044146 | 19 | 0.656 | |
| membrane organization | GO:0061024 | 245 | 0.656 | Human |
| regulation of lipid storage | GO:0010883 | 20 | 0.654 | |
| steroid catabolic process | GO:0006706 | 7 | 0.654 | |
| macrophage derived foam cell differentiation | GO:0010742 | 6 | 0.650 | |
| regulation of secretion | GO:0051046 | 274 | 0.650 | |
| receptor mediated endocytosis | GO:0006898 | 51 | 0.645 | Human |
| metanephric glomerular epithelium development | GO:0072244 | 3 | 0.643 | |
| regulation of lipid transport | GO:0032368 | 36 | 0.640 | Human Mouse |
| muscle tissue development | GO:0060537 | 308 | 0.639 | |
| regulation of response to reactive oxygen species | GO:1901031 | 9 | 0.637 | |
| immune effector process | GO:0002252 | 321 | 0.637 | |
| fat soluble vitamin biosynthetic process | GO:0042362 | 4 | 0.636 | |
| ammonia assimilation cycle | GO:0019676 | 2 | 0.636 | |
| cellular response to oxidative stress | GO:0034599 | 76 | 0.636 | |
| platelet derived growth factor receptor alpha signaling pathway | GO:0035790 | 3 | 0.627 | |
| monocarboxylic acid metabolic process | GO:0032787 | 191 | 0.623 | |
| endocytosis | GO:0006897 | 168 | 0.622 | Human |
| negative regulation of beta amyloid formation | GO:1902430 | 4 | 0.620 | Human |
| negative regulation of planar cell polarity pathway involved in heart morphogenesis | GO:2000160 | 1 | 0.619 | |
| regulation of lipid metabolic process | GO:0019216 | 118 | 0.618 | |
| macromolecule catabolic process | GO:0009057 | 281 | 0.617 | |
| regulation of map kinase activity | GO:0043405 | 120 | 0.616 | Human |
| neuronal action potential | GO:0019228 | 54 | 0.616 | |
| regulation of inflammatory response to antigenic stimulus | GO:0002861 | 21 | 0.616 | |
| inflammatory response | GO:0006954 | 244 | 0.613 | |
| response to estrogen | GO:0043627 | 24 | 0.605 | |
| regulation of protein tyrosine kinase activity | GO:0061097 | 17 | 0.604 | |
| lipoprotein transport | GO:0042953 | 7 | 0.603 | |
| granulocyte migration | GO:0097530 | 43 | 0.602 | |
| phagocytosis | GO:0006909 | 66 | 0.602 | |
| high density lipoprotein particle remodeling | GO:0034375 | 4 | 0.601 | Human |
| positive regulation of sequence specific dna binding transcription factor activity | GO:0051091 | 68 | 0.601 | |
| lytic vacuole organization | GO:0080171 | 21 | 0.600 | |
| regulation of hypersensitivity | GO:0002883 | 10 | 0.600 | |
| oligodendrocyte differentiation | GO:0048709 | 53 | 0.599 | |
| extrinsic apoptotic signaling pathway | GO:0097191 | 126 | 0.599 | |
| lipid biosynthetic process | GO:0008610 | 179 | 0.596 | Human Mouse |
| regulation of planar cell polarity pathway involved in neural tube closure | GO:2000167 | 1 | 0.595 | |
| negative regulation of planar cell polarity pathway involved in outflow tract morphogenesis | GO:2000164 | 1 | 0.594 | |
| response to tumor necrosis factor | GO:0034612 | 26 | 0.592 | |
| positive regulation of cholesterol esterification | GO:0010873 | 1 | 0.583 | |
| innate immune response | GO:0045087 | 157 | 0.579 | Mouse |
| regulation of stem cell proliferation | GO:0072091 | 78 | 0.577 | |
| negative regulation of phagocytosis | GO:0050765 | 4 | 0.573 | |
| regulation of engulfment of apoptotic cell | GO:1901074 | 2 | 0.573 | |
| positive regulation of macrophage derived foam cell differentiation | GO:0010744 | 4 | 0.572 | |
| negative regulation of planar cell polarity pathway involved in ventricular septum morphogenesis | GO:2000149 | 1 | 0.570 | |
| canonical wnt signaling pathway involved in neural crest cell differentiation | GO:0044335 | 1 | 0.568 | |
| cellular response to increased oxygen levels | GO:0036295 | 1 | 0.566 | |
| response to corticosteroid | GO:0031960 | 20 | 0.562 | |
| cellular response to superoxide | GO:0071451 | 14 | 0.561 | |
| response to iron ion | GO:0010039 | 4 | 0.556 | |
| granulocyte chemotaxis | GO:0071621 | 39 | 0.553 | |
| positive regulation of cytokine secretion | GO:0050715 | 41 | 0.552 | |
| ensheathment of neurons | GO:0007272 | 76 | 0.547 | |
| positive regulation of adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | GO:0002824 | 61 | 0.546 | |
| canonical wnt signaling pathway involved in regulation of cell proliferation | GO:0044340 | 3 | 0.545 | |
| positive regulation of map kinase activity | GO:0043406 | 84 | 0.545 | |
| low density lipoprotein particle remodeling | GO:0034374 | 2 | 0.543 | |
| response to vitamin | GO:0033273 | 6 | 0.543 | |
| cardiocyte differentiation | GO:0035051 | 87 | 0.542 | |
| regulation of cholesterol efflux | GO:0010874 | 13 | 0.541 | Human |
| drug metabolic process | GO:0017144 | 4 | 0.540 | |
| digestive tract development | GO:0048565 | 190 | 0.540 | |
| hypersensitivity | GO:0002524 | 10 | 0.539 | |
| negative regulation of cholesterol transport | GO:0032375 | 4 | 0.539 | Human |
| cellular response to lipid | GO:0071396 | 145 | 0.537 | |
| negative regulation of defense response | GO:0031348 | 77 | 0.535 | |
| triglyceride catabolic process | GO:0019433 | 9 | 0.533 | |
| positive regulation of type ii hypersensitivity | GO:0002894 | 4 | 0.532 | |
| immune complex clearance | GO:0002434 | 2 | 0.529 | |
| activation of mapk activity | GO:0000187 | 59 | 0.528 | |
| regulation of wound healing | GO:0061041 | 40 | 0.527 | Human |
| regulation of toll like receptor 4 signaling pathway | GO:0034143 | 4 | 0.525 | |
| response to acid chemical | GO:0001101 | 111 | 0.521 | |
| regulation of vesicle mediated transport | GO:0060627 | 139 | 0.514 | |
| response to vitamin a | GO:0033189 | 1 | 0.511 | |
| tissue remodeling | GO:0048771 | 102 | 0.510 | |
| protein localization to organelle | GO:0033365 | 185 | 0.504 | |
| lung development | GO:0030324 | 164 | 0.501 | |
| apoptotic cell clearance | GO:0043277 | 17 | 0.501 | |
| hepaticobiliary system development | GO:0061008 | 67 | 0.499 | |
| regulation of type iia hypersensitivity | GO:0001796 | 4 | 0.498 | |
| cell type specific apoptotic process | GO:0097285 | 268 | 0.492 | |
| hindbrain radial glia guided cell migration | GO:0021932 | 12 | 0.490 | |
| regulation of proteolysis | GO:0030162 | 164 | 0.489 | Human |
| positive regulation of acute inflammatory response | GO:0002675 | 16 | 0.489 | |
| ras protein signal transduction | GO:0007265 | 77 | 0.488 | Human |
| carboxylic acid biosynthetic process | GO:0046394 | 86 | 0.487 | |
| cellular response to transforming growth factor beta stimulus | GO:0071560 | 88 | 0.487 | |
| brown fat cell differentiation | GO:0050873 | 36 | 0.486 | |
| positive regulation of triglyceride biosynthetic process | GO:0010867 | 6 | 0.484 | |
| regulation of insulin receptor signaling pathway | GO:0046626 | 21 | 0.484 | |
| response to chromate | GO:0046687 | 1 | 0.483 | |
| insulin receptor signaling pathway | GO:0008286 | 49 | 0.483 | |
| regulation of cholesterol storage | GO:0010885 | 4 | 0.480 | |
| regulation of protein kinase b signaling | GO:0051896 | 56 | 0.480 | |
| regulation of leukocyte mediated immunity | GO:0002703 | 104 | 0.479 | |
| negative regulation of angiogenesis | GO:0016525 | 25 | 0.478 | |
| regulation of planar cell polarity pathway involved in pericardium morphogenesis | GO:2000165 | 1 | 0.477 | |
| response to interleukin 1 | GO:0070555 | 11 | 0.473 | |
| negative regulation of cellular protein metabolic process | GO:0032269 | 247 | 0.473 | Human |
| positive regulation of keratinocyte differentiation | GO:0045618 | 3 | 0.472 | |
| cellular macromolecule catabolic process | GO:0044265 | 206 | 0.467 | Human |
| cardiac muscle cell differentiation | GO:0055007 | 69 | 0.467 | |
| epithelial cell proliferation | GO:0050673 | 174 | 0.466 | Human Mouse |
| negative regulation of cellular amide metabolic process | GO:0034249 | 4 | 0.461 | Human |
| positive regulation of protein ubiquitination involved in ubiquitin dependent protein catabolic process | GO:2000060 | 8 | 0.460 | |
| lipoprotein biosynthetic process | GO:0042158 | 33 | 0.453 | |
| positive regulation of growth | GO:0045927 | 104 | 0.452 | |
| spinal cord development | GO:0021510 | 81 | 0.448 | |
| cytokine production involved in immune response | GO:0002367 | 34 | 0.448 | |
| camera type eye development | GO:0043010 | 266 | 0.446 | |
| urea metabolic process | GO:0019627 | 3 | 0.445 | |
| production of molecular mediator of immune response | GO:0002440 | 103 | 0.443 | |
| production of molecular mediator involved in inflammatory response | GO:0002532 | 21 | 0.442 | |
| exogenous drug catabolic process | GO:0042738 | 1 | 0.441 | |
| oxidation reduction process | GO:0055114 | 342 | 0.440 | Human |
| regulation of protein catabolic process | GO:0042176 | 108 | 0.439 | Human |
| negative regulation of multi organism process | GO:0043901 | 68 | 0.436 | |
| negative regulation of molecular function | GO:0044092 | 258 | 0.434 | Human Mouse |
| positive regulation of protein transport | GO:0051222 | 93 | 0.432 | |
| negative regulation of endocytosis | GO:0045806 | 12 | 0.432 | |
| response to retinoic acid | GO:0032526 | 56 | 0.428 | |
| regulation of cellular response to stress | GO:0080135 | 159 | 0.428 | |
| leukocyte migration | GO:0050900 | 124 | 0.426 | |
| positive regulation of transcription from rna polymerase ii promoter in response to stress | GO:0036003 | 3 | 0.426 | |
| small molecule biosynthetic process | GO:0044283 | 132 | 0.426 | Human Mouse |
| negative regulation of platelet derived growth factor receptor beta signaling pathway | GO:2000587 | 2 | 0.423 | |
| nitrogen cycle metabolic process | GO:0071941 | 3 | 0.422 | |
| lymphocyte migration | GO:0072676 | 26 | 0.420 | |
| negative regulation of neuron death | GO:1901215 | 98 | 0.418 | Human |
| skeletal system development | GO:0001501 | 356 | 0.416 | |
| regulation of glutamate metabolic process | GO:2000211 | 1 | 0.415 | |
| response to oxidative stress | GO:0006979 | 123 | 0.414 | |
| t cell migration | GO:0072678 | 19 | 0.411 | |
| developmental cell growth | GO:0048588 | 84 | 0.410 | |
| regulation of urea metabolic process | GO:0034255 | 1 | 0.410 | |
| cellular zinc ion homeostasis | GO:0006882 | 9 | 0.409 | |
| growth of symbiont in host | GO:0044117 | 23 | 0.408 | |
| negative regulation of neuron apoptotic process | GO:0043524 | 92 | 0.408 | |
| response to hypoxia | GO:0001666 | 58 | 0.408 | |
| metal ion homeostasis | GO:0055065 | 189 | 0.406 | |
| activation of mapk activity involved in innate immune response | GO:0035419 | 2 | 0.405 | |
| peptide metabolic process | GO:0006518 | 46 | 0.403 | Human |
| growth of symbiont involved in interaction with host | GO:0044116 | 23 | 0.401 | |
| cognition | GO:0050890 | 149 | 0.401 | |
| protein catabolic process | GO:0030163 | 221 | 0.400 | |
| regulation of neuron apoptotic process | GO:0043523 | 122 | 0.399 | |
| positive regulation of triglyceride lipase activity | GO:0061365 | 3 | 0.399 | |
| steroid biosynthetic process | GO:0006694 | 47 | 0.398 | Human Mouse |
| negative regulation of planar cell polarity pathway involved in cardiac muscle tissue morphogenesis | GO:2000151 | 1 | 0.398 | |
| regulation of ammonia assimilation cycle | GO:2001248 | 1 | 0.397 | |
| digestive system development | GO:0055123 | 200 | 0.394 | |
| negative regulation of cellular component organization | GO:0051129 | 194 | 0.393 | Human |
| regulation of tube size | GO:0035150 | 57 | 0.393 | |
| regulation of body fluid levels | GO:0050878 | 162 | 0.390 | Human |
| regulation of phagocytosis | GO:0050764 | 33 | 0.385 | |
| negative regulation of hydrolase activity | GO:0051346 | 71 | 0.382 | Mouse |
| transforming growth factor beta receptor signaling pathway | GO:0007179 | 71 | 0.379 | |
| negative regulation of lipoprotein lipase activity | GO:0051005 | 1 | 0.378 | |
| regulation of b cell mediated immunity | GO:0002712 | 37 | 0.377 | |
| regulation of complement activation | GO:0030449 | 7 | 0.375 | |
| regulation of blood coagulation | GO:0030193 | 28 | 0.374 | Human |
| protein secretion | GO:0009306 | 111 | 0.374 | |
| positive regulation of activation of membrane attack complex | GO:0001970 | 2 | 0.372 | |
| positive regulation of nervous system development | GO:0051962 | 221 | 0.372 | Human |
| metanephric mesenchymal cell migration | GO:0035789 | 2 | 0.372 | |
| positive regulation of b cell mediated immunity | GO:0002714 | 26 | 0.372 | |
| transmembrane transport | GO:0055085 | 412 | 0.369 | |
| response to bile acid | GO:1903412 | 1 | 0.368 | |
| release of cytochrome c from mitochondria | GO:0001836 | 23 | 0.368 | |
| molting cycle | GO:0042303 | 90 | 0.365 | |
| positive regulation of cholesterol storage | GO:0010886 | 3 | 0.363 | |
| urea cycle | GO:0000050 | 2 | 0.362 | |
| canonical wnt signaling pathway involved in heart development | GO:0061316 | 3 | 0.362 | |
| positive regulation of adaptive immune response | GO:0002821 | 61 | 0.361 | |
| erythrocyte differentiation | GO:0030218 | 88 | 0.360 | |
| cellular response to retinoic acid | GO:0071300 | 25 | 0.360 | |
| response to fluid shear stress | GO:0034405 | 7 | 0.360 | |
| positive regulation of nitric oxide synthase activity | GO:0051000 | 2 | 0.358 | Human |
| positive regulation of dendrite development | GO:1900006 | 21 | 0.358 | Human |
| myelination | GO:0042552 | 74 | 0.357 | |
| anion transport | GO:0006820 | 177 | 0.357 | Human |
| regulation of type ii hypersensitivity | GO:0002892 | 4 | 0.356 | |
| positive regulation of tumor necrosis factor superfamily cytokine production | GO:1903557 | 31 | 0.354 | |
| engulfment of apoptotic cell | GO:0043652 | 3 | 0.353 | |
| positive regulation of hypersensitivity | GO:0002885 | 7 | 0.352 | |
| regulation of blood pressure | GO:0008217 | 93 | 0.352 | |
| regulation of reverse cholesterol transport | GO:1903062 | 1 | 0.351 | |
| muscle contraction | GO:0006936 | 101 | 0.351 | |
| glucocorticoid metabolic process | GO:0008211 | 9 | 0.347 | Mouse |
| peptide secretion | GO:0002790 | 114 | 0.346 | |
| response to transition metal nanoparticle | GO:1990267 | 11 | 0.346 | |
| myeloid leukocyte migration | GO:0097529 | 57 | 0.342 | |
| positive regulation of acute inflammatory response to antigenic stimulus | GO:0002866 | 7 | 0.341 | |
| negative regulation of extrinsic apoptotic signaling pathway | GO:2001237 | 45 | 0.340 | |
| positive regulation of fat cell differentiation | GO:0045600 | 32 | 0.337 | |
| interspecies interaction between organisms | GO:0044419 | 83 | 0.336 | |
| canonical wnt signaling pathway involved in cardiac neural crest cell differentiation involved in heart development | GO:0061310 | 1 | 0.336 | |
| sphingolipid metabolic process | GO:0006665 | 45 | 0.335 | |
| negative regulation of endothelial cell apoptotic process | GO:2000352 | 7 | 0.334 | |
| blood coagulation | GO:0007596 | 76 | 0.334 | Human |
| cellular response to fluid shear stress | GO:0071498 | 4 | 0.333 | |
| positive regulation of creb transcription factor activity | GO:0032793 | 4 | 0.331 | |
| regulation of cholesterol homeostasis | GO:2000188 | 9 | 0.330 | |
| regulation of rho protein signal transduction | GO:0035023 | 71 | 0.328 | Human |
| glutamate metabolic process | GO:0006536 | 9 | 0.327 | |
| kidney development | GO:0001822 | 213 | 0.325 | |
| epidermis development | GO:0008544 | 187 | 0.325 | |
| tyrosine phosphorylation of stat1 protein | GO:0042508 | 3 | 0.320 | |
| negative regulation of protein maturation | GO:1903318 | 79 | 0.319 | |
| cellular response to biotic stimulus | GO:0071216 | 92 | 0.313 | |
| cardiac muscle tissue development | GO:0048738 | 130 | 0.313 | |
| negative regulation of proteolysis | GO:0045861 | 74 | 0.313 | |
